VANGUARD GROUP INC

Holdings History for RAPT Therapeutics, Inc. - Common Stock, $0.0001 par value per share (RAPT)

Symbol: RAPT on Nasdaq
Investment type: Equity - Shares of Stock
Class: Common Stock, $0.0001 par value per share
Latest Disclosed Ownership: 2.93M shares
Security Ownership: 2.22%

Shares, Excluding Options vs Price

Value, Excluding Options

The Vanguard Group ownership in RAPT Therapeutics, Inc. Common Stock, $0.0001 par value per share (RAPT)

2025-02-07 - The Vanguard Group has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 2.93M shares of RAPT Therapeutics, Inc. Common Stock, $0.0001 par value per share (RAPT). This represents 2.22% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
The Vanguard Group	2.22%		$3.58M	2.93M			$1.22	13G/A	1/31/2025	7 Feb 2025 17:31:51
The Vanguard Group	2.22%		$3.58M	2.93M			$1.22	13G/A	1/31/2025	7 Feb 2025 17:31:51

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
12/31/2024	0%	0%	$4.65M	2.94M	-214,656	-6.8%	$1.58	Q4 2024
9/30/2024	0%	+0%	$6.34M	3.16M	+47,737	+1.54%	$2.01	Q3 2024
6/30/2024	0%		$9.48M	3.11M			$3.05	Q2 2024
3/31/2024	0%		$22.4M	2.49M			$8.98^*	Q1 2024
12/31/2023	0%	+0%	$51.1M	2.06M	+32,916	+1.63%	$24.85	Q4 2023
9/30/2023	0%	+0%	$33.6M	2.02M	+76,356	+3.92%	$16.62	Q3 2023
6/30/2023	0%	+0%	$36.4M	1.95M	+365,431	+23.1%	$18.70	Q2 2023
3/31/2023	0%	+0%	$29M	1.58M	+74,345	+4.93%	$18.35	Q1 2023
12/31/2022	0%	+0%	$29.8M	1.51M	+223,265	+17.4%	$19.80	Q4 2022
9/30/2022	0%	+0%	$30.9M	1.28M	+18,363	+1.45%	$24.06	Q3 2022
6/30/2022	0%	+0%	$23.1M	1.27M	+41,000	+3.35%	$18.25	Q2 2022
3/31/2022	0%	+0%	$26.9M	1.22M	+18,193	+1.51%	$21.99	Q1 2022
12/31/2021	0%	+0%	$44.3M	1.21M	+127,466	+11.8%	$36.73	Q4 2021
9/30/2021	0%	+0%	$33.5M	1.08M	+164,970	+18.1%	$31.05	Q3 2021
6/30/2021	0%	+0%	$29.1M	914K	+162,516	+21.6%	$31.79	Q2 2021
3/31/2021	0%		$16.7M	751K			$22.20	Q1 2021
12/31/2020	0%	+0%	$14.5M	733K	+148,172	+25.3%	$19.75^*	Q4 2020
9/30/2020	0%	+0%	$18.8M	585K	+127,864	+28%	$32.20	Q3 2020
6/30/2020	0%	+0%	$13.3M	457K	+176,907	+63.1%	$29.02	Q2 2020
3/31/2020	0%	+0%	$5.96M	280K	+136,527	+95%	$21.27	Q1 2020
12/31/2019	0%	+0%	$3.97M	144K	+143,723	NEW	$27.61	Q4 2019

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.